Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

AstraZeneca's Forxiga For Type 2 Diabetes Is A Potential Blockbuster
Seeking Alpha
Friday, November 16, 2012 - 10:13am
tags:
AstraZeneca, Forxiga, diabetes, Dapagliflozin
Novartis wins EU okay for first meningitis B vaccine
Reuters
Friday, November 16, 2012 - 10:12am
tags:
Novartis, EMA, Europe, meningitis B, vaccines, Bexsero
Biocon, Bristol-Myers in deal for oral insulin drug
Reuters
Friday, November 16, 2012 - 10:10am
tags:
Biocon, Bristol-Myers Squibb, insulin, diabetes, IN-105
Dynavax Shares Pummelled After FDA Panel
Motley Fool
Friday, November 16, 2012 - 10:10am
tags:
FDA, advisory panels, Dynavax, Heplisav, hepatitis B, vaccines
Reckitt trumps Bayer with $1.4 bln bid for Schiff
Reuters
Friday, November 16, 2012 - 10:09am
tags:
Reckitt Benckiser, Bayer AG, Schiff, M&A
Trovagene's Foray Into The Conventions Of Molecular Diagnostics
Seeking Alpha
Thursday, November 15, 2012 - 4:38pm
tags:
TrovaGene, molecular diagnostics, Sequenom, Hologic, Quest Diagnostics
Are Arena and VIVUS Frenemies?
Motley Fool
Thursday, November 15, 2012 - 4:36pm
tags:
Arena Pharmaceuticals, Vivus, Qsymia, Belviq, obesity
5 Drug Hopefuls That Are Going to Change Your Life: Part 1
Motley Fool
Thursday, November 15, 2012 - 4:25pm
tags:
BG-12, Biogen Idec, MS, multiple sclerosis
Synergy Pharma shoots higher on plecanatide plans
Yahoo/AP
Thursday, November 15, 2012 - 11:59am
tags:
plecanatide, Synergy Pharmaceuticals
After The Bloodbath, Where Does Pharmacyclics Go From Here?
Seeking Alpha
Thursday, November 15, 2012 - 11:58am
tags:
Pharmacyclics, earnings
MAP Pharma's Awkward FDA Silence
TheStreet.com
Thursday, November 15, 2012 - 11:57am
tags:
FDA, MAP Pharmaceuticals, migraines, Levadex
Upstart Valor launches with plans to develop armed antibody cancer drugs
Fierce Biotech
Thursday, November 15, 2012 - 11:35am
tags:
Valor, armed-antibodies, cancer
Tranzyme Stomach Paralysis Drug Comes Up Short
TheStreet.com
Thursday, November 15, 2012 - 11:33am
tags:
stomach paralysis, Tranzyme
Alnylam: No Approved Drugs, No Promising Candidates, No Justification For $1 Billion Valuation
Seeking Alpha
Thursday, November 15, 2012 - 11:32am
tags:
Alnylam
J&J, Lilly, Merck plan clinical trial site database
Reuters
Thursday, November 15, 2012 - 11:13am
tags:
JNJ, Eli Lilly, Merck, clinical trials
Gilead's single tablet Stribild shows positive results in two HIV studies
Yahoo/Fly on the Wall
Thursday, November 15, 2012 - 11:11am
tags:
HIV, Stribild, Gilead
Merck KGaA expects to publish Stimuvax data in Q1 2013
Reuters
Thursday, November 15, 2012 - 11:09am
tags:
Merck KGaA, Stimuvax, vaccines, cancer, Oncothyreon
Incyte Achieves $50 Million Milestone as Oral JAK1/JAK2 Inhibitor Baricitinib Advances into Phase III Development for Rheumatoid Arthritis
Yahoo
Thursday, November 15, 2012 - 11:06am
tags:
baricitinib, Incyte, JAK inhibitors, Eli Lilly, rheumatoid arthritis
The Other Side Of Galena Biopharma
Seeking Alpha
Thursday, November 15, 2012 - 11:06am
tags:
Galena Biopharma
GlaxoSmithKline says FDA panel recommends approval of H5N1 flu vaccine
The Fly on the Wall
Thursday, November 15, 2012 - 10:57am
tags:
FDA, advisory panels, H5N1, vaccines, GSK

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.